The Research and Development team at RayzeBio focuses on the discovery and innovation of targeted radiopharmaceuticals for solid tumors. This interdisciplinary team, comprising experts in chemistry, biology, and clinical operations, collaborates to advance drug development from initial concept through preclinical studies, ensuring that new therapies are both effective and safe for cancer patients.